Acumen Pharmaceuticals, Inc. (ABOS): Shares Outstanding

Annual figures by period end, from SEC filings.

60.58M
As of 2025-12-31
72.31M
As of 2026-06-30
+13.9%
3-year compound annual growth
n/m
5-year compound annual growth
2020-12-31: 419.1K2021-12-31: 40.47M2022-12-31: 41.03M2023-12-31: 57.91M2024-12-31: 60.09M2025-12-31: 60.58M60.58M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3160.58M+0.8%2026-03-26, Balance as of period end
2024-12-3160.09M+3.8%2026-03-26, Balance as of period end
2023-12-3157.91M+41.2%2025-03-27, Balance as of period end
2022-12-3141.03M+1.4%2024-03-26, Balance as of period end
2021-12-3140.47Mn/m2023-03-27, Balance as of period end
2020-12-31419.1Kn/a2022-03-28, Balance as of period end